Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Michael Dudley Insider Profile
4 Followers
Robert Michael Dudley, CEO, Director at TransCode Therapeutics, holds 180.26K shares in TransCode Therapeutics (Ticker: RNAZ). Most recently, Robert Michael Dudley Bought $98,000 shares of TransCode Therapeutics on Oct 02, 2023 for an estimated value of 49.98K.
Robert Michael Dudley TransCode Therapeutics (RNAZ)CEO, Director
TransCode Therapeutics (RNAZ)
CEO, Director
Ranked #95,009 out of 98,042 Corporate Insiders
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-95.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Robert Michael Dudley's holdings
Insider Roles
CEO, Director
Roles that Robert Michael Dudley holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 01, 2022 - Jun 01, 2023
Return:-89.10%
The most profitable trade made by Robert Michael Dudley
Robert Michael Dudley's Trading History
List of latest transactions for each holding click on a transaction to see Robert Michael Dudley's performance on stock
You May Also Like
Robert Michael Dudley insider profile FAQ
What is the percentage of profitable transactions made by Robert Michael Dudley?
The percentage of profitable transactions made by Robert Michael Dudley is 0%.
What is the average return per transaction made by Robert Michael Dudley?
The average return per transaction made by Robert Michael Dudley is -95.80%.
What stocks does Robert Michael Dudley hold?
Robert Michael Dudley holds: RNAZ stocks.
What was Robert Michael Dudley’s latest transaction?
Robert Michael Dudley latest transaction was an Informative Buy of $49.98K.
What was Robert Michael Dudley's most profitable transaction?
Robert Michael Dudley’s most profitable transaction was an Informative Buy of RNAZ stock on June 1, 2022. The return on the trade was -89.10%.
What is Robert Michael Dudley's role in TransCode Therapeutics?
Robert Michael Dudley's role in TransCode Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.